Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by gpeon Mar 19, 2004 9:20pm

306 Views

Post# 7238979

RE: TMM9

Can we please, please get this board back on track and focused on the discussion of Oncolytics. I'm a person that allows for a heck of a lot of lattitude, but this is getting ridiculous. If you really want to talk about injustices to native people, the rights and wrongs of hunting, and your personal political stances and views please call your friends and go to the bar! If you don't have any friends, I'm sure there are other support groups you can join on the internet. This has gotten way off track!

Bullboard Posts

Changing Europe’s dependency on HREE from China